ストックスクリーナーアプリを入手
2.06
0.49%
0.01
アフターアワーズ：
2.28
0.22
+10.68%
前日終値:
$2.05
開ける：
$2.01
24時間の取引高:
141.37K
Relative Volume:
0.05
時価総額：
$9.22M
収益：
$9.37M
当期純損益:
$-8.45M
株価収益率:
-2.5432
EPS:
-0.81
ネットキャッシュフロー:
$-7.27M
1週間 パフォーマンス:
-15.92%
1か月 パフォーマンス:
-15.92%
6か月 パフォーマンス:
-67.73%
1年 パフォーマンス:
-94.80%
1日の値動き範囲:
$1.91
$2.0999
1週間の範囲:
$1.91
$2.425
52週間の値動き範囲:
$1.91
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
名前
Bioaffinity Technologies Inc
セクター
電話
210-698-5334
住所
3300 NACOGDOCHES ROAD, SAN ANTONIO
BIAF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
2.06 | 9.22M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
572.41 | 212.64B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
209.94 | 148.81B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
708.45 | 56.99B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.74 | 41.81B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.46 | 35.91B | 15.90B | 1.28B | 2.21B | 7.2842 |
Bioaffinity Technologies Inc (BIAF) 最新ニュース
bioAffinity Technologies Hits 52-Week Low at $2.27 Amidst 94% Decline - Markets Mojo
Strategies to average down on bioAffinity Technologies Inc.2025 Pullback Review & AI Driven Price Forecasts - newser.com
Will bioAffinity Technologies Inc. stock see insider buyingMarket Activity Summary & Community Consensus Stock Picks - newser.com
Can a trend reversal in bioAffinity Technologies Inc. lead to recoveryQuarterly Earnings Summary & Smart Swing Trading Techniques - newser.com
Can volume confirm reversal in bioAffinity Technologies Inc.Earnings Growth Report & Real-Time Volume Analysis - newser.com
Multi factor analysis applied to bioAffinity Technologies Inc. Equity WarrantJuly 2025 Recap & Daily Price Action Insights - newser.com
What dividend safety score for bioAffinity Technologies Inc. Equity Warrant stock2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Applying Elliott Wave Theory to bioAffinity Technologies Inc. Equity WarrantGold Moves & Precise Entry and Exit Recommendations - newser.com
What to do if you’re stuck in bioAffinity Technologies Inc. Equity Warrant2025 Top Decliners & Community Consensus Trade Signals - newser.com
Trend analysis for bioAffinity Technologies Inc. Equity Warrant this weekWeekly Market Outlook & Accurate Intraday Trade Tips - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock outperform value stocksQuarterly Portfolio Report & Consistent Growth Equity Picks - newser.com
Risk adjusted return profile for bioAffinity Technologies Inc. Equity Warrant analyzedQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
How to interpret RSI for bioAffinity Technologies Inc. stock2025 Stock Rankings & Smart Money Movement Tracker - newser.com
Using portfolio simulators with bioAffinity Technologies Inc. includedQuarterly Portfolio Summary & Smart Allocation Stock Tips - newser.com
Why bioAffinity Technologies Inc. stock is seen as undervaluedJuly 2025 Fed Impact & High Return Stock Watch Alerts - fcp.pa.gov.br
BioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath(R) Lung Test Volume - MarketScreener
Can bioAffinity Technologies Inc. stock resist sector downturnsJuly 2025 Trade Ideas & Smart Money Movement Alerts - newser.com
Has bioAffinity Technologies Inc. Equity Warrant found a price floor2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
Can momentum traders help lift bioAffinity Technologies Inc. Equity WarrantQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Real time breakdown of bioAffinity Technologies Inc. stock performanceJuly 2025 Retail & Free Reliable Trade Execution Plans - newser.com
Is bioAffinity Technologies Inc. meeting your algorithmic filter criteria2025 Price Momentum & Breakout Confirmation Alerts - newser.com
bioAffinity reports 111% increase in lung cancer test volume By Investing.com - Investing.com Nigeria
Sector ETF performance correlation with bioAffinity Technologies Inc.Weekly Risk Summary & Smart Allocation Stock Reports - newser.com
What catalysts could drive bioAffinity Technologies Inc. stock higherMarket Volume Summary & Short-Term Trading Alerts - fcp.pa.gov.br
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume - BioSpace
Leading vs lagging indicators on bioAffinity Technologies Inc. Equity Warrant performanceBuy Signal & Consistent Return Investment Signals - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock outperform Dow Jones indexFed Meeting & Real-Time Sentiment Analysis - newser.com
bioAffinity Technologies Hits New 52-Week Low at $2.05 - Markets Mojo
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trends2025 Winners & Losers & Fast Exit and Entry Strategy Plans - newser.com
Can bioAffinity Technologies Inc. stock maintain operating marginsWeekly Trade Report & Fast Gaining Stock Reports - newser.com
bioAffinity Technologies Reports Surge in CyPath® Lung Tests - MSN
How institutional buying supports bioAffinity Technologies Inc. Equity Warrant stockPrice Action & Stepwise Entry/Exit Trade Alerts - newser.com
What recovery options are there for bioAffinity Technologies Inc.2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com
Is a relief rally coming for bioAffinity Technologies Inc. holdersEarnings Recap Summary & Consistent Income Trade Ideas - newser.com
Will bioAffinity Technologies Inc. stock see PE expansionPortfolio Value Report & Smart Investment Allocation Insights - fcp.pa.gov.br
bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Volume - TradingView
bioAffinity reports 111% increase in lung cancer test volume - Investing.com
Is bioAffinity Technologies Inc. stock oversold or undervaluedTrade Exit Summary & Real-Time Buy Zone Alerts - newser.com
Has bioAffinity Technologies Inc. Equity Warrant formed a bullish divergenceJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Is bioAffinity Technologies Inc. stock cheap compared to fundamentalsJuly 2025 Highlights & Consistent Growth Stock Picks - newser.com
Bioaffinity Technologies Inc (BIAF) 財務データ
収益
当期純利益
現金流量
EPS
1.69%
0.02%
大文字化:
|
ボリューム (24 時間):